Vericel Corporation DSO Ratio 2011-2026 | VCEL

Annual DSO Ratio Vericel Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
96.5	92.1	96.9	93.2	84.1	98	99.6	94.2	104	115	77.9	104	-	487	182	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
487	77.9	130

Quarterly DSO Ratio Vericel Corporation

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
88.6	84.3	84.5	99.1	-	76	84.8	96.3	-	78.1	76.2	94.4	-	40.6	39.2	87.6	-	80.2	70.3	84	69.6	97.6	157	114	74.5	96.2	112	116	68.3	95.2	113	106	71.4	117	98.3	172	94.4	143	122	90.6	64.6	88.1	73.3	80.4	50.8	77.4	169	-	-	-	122	160	88.8	411	456	456	-	91.2	91.2	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
456	39.2	115

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	2.94 K	-	5743.5 %	$ 69.7 M	Canada
Coherus BioSciences CHRS	559	$ 1.57	-3.68 %	$ 184 M	USA
Happiness Biotech Group Limited HAPP	29	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	70.9	$ 16.87	-2.49 %	$ 789 M	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 7.47	-4.6 %	$ 205 M	Israel
Eton Pharmaceuticals ETON	39.1	$ 30.26	1.0 %	$ 814 M	USA
Exelixis EXEL	43.4	$ 50.13	-1.9 %	$ 13.6 B	USA
Fortress Biotech FBIO	115	$ 2.41	4.78 %	$ 67.2 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
AbCellera Biologics ABCL	173	$ 4.09	-7.05 %	$ 1.22 B	Canada
Autolus Therapeutics plc AUTL	58.2	$ 1.63	2.52 %	$ 434 M	Britain
Celyad Oncology SA CYAD	64.4	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
IMV IMV	2.16 K	-	-	$ 13.1 M	Canada
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Gilead Sciences GILD	57.8	$ 129.58	-1.88 %	$ 161 B	USA
Advaxis ADXS	3.28 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.36	-3.72 %	$ 5.53 M	Israel
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Esperion Therapeutics ESPR	99.7	$ 3.12	-	$ 649 M	USA
Genmab A/S GMAB	97.9	$ 26.54	-1.34 %	$ 1.72 B	Danmark
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA